Lemaitre Vascular (LMAT) Revenue (2010 - 2026)

Lemaitre Vascular (LMAT) has 17 years of Revenue data on file, last reported at $66.6 million in Q1 2026.

• Revenue for Q1 2026 came in at $66.6 million, up 11.16% year-over-year; the trailing twelve-month figure through Mar 2026 was $256.3 million (up 13.27% YoY), and the FY2025 annual result was $249.6 million, up 13.53% from the prior year.
• Revenue grew to $66.6 million in Q1 2026 per LMAT's latest filing, from $64.5 million in the prior quarter.
• Over five years, Revenue peaked at $66.6 million in Q1 2026 and troughed at $39.0 million in Q3 2022.
• A 5-year average of $52.4 million and a median of $53.5 million in 2024 frame the typical range for Revenue.
• The sharpest annual moves came in 2022 and 2023: Revenue gained 1.72% in 2022, then gained 21.48% in 2023.
• A 5-year view of Revenue shows it stood at $41.0 million in 2022, then rose by 19.36% to $48.9 million in 2023, then advanced by 13.98% to $55.7 million in 2024, then rose by 15.68% to $64.5 million in 2025, then gained by 3.26% to $66.6 million in 2026.
• Business Quant data shows LMAT's Revenue at $66.6 million in Q1 2026, $64.5 million in Q4 2025, and $61.0 million in Q3 2025.